
Investing.com -- U.S. stocks were falling as investors awaited the minutes of the latest Federal Reserve policy meeting.
At 11:23 ET (15:23 GMT), the Dow Jones Industrial Average was down 66 points or 0.2%, while the S&P 500 was down 0.1% and the NASDAQ Composite was down 0.1%.
The Fed will release the minutes of its June meeting this afternoon, giving investors a chance to hunt for clues on the central bank’s monetary path as it heads into its next meeting this month.
The Fed paused on hikes in June but indicated more hikes were coming this year. Futures traders are giving an 88% probability of a quarter of a percentage point increase in July. They are also giving a 33% probability that another increase will come in November.
Economic data this week include factory orders, private payrolls and job openings and the comprehensive job report for June, which is due out on Friday. Factory orders rose a weaker than expected 0.3% in May from the prior month.
Chip stocks were falling after China put export controls on key metals used in the industry, raising tensions with the U.S. over access to the sensitive technology. Shares of Micron Technology, Inc. (NASDAQ:MU) were down 2.2%, and Intel Corporation (NASDAQ:INTC) was down 2%.
The main stock indexes in the U.S. started off the second half of the year on a positive note, lifted by record deliveries posted by Tesla (NASDAQ:TSLA) for the second quarter.
Tech stocks jumped in the first half of the year, boosted by enthusiasm for all things related to artificial intelligence, leading the Nasdaq to a 32% year-to-date increase. The S&P had its best first half since before the pandemic, rising 16%.
AstraZeneca PLC ADR (NASDAQ:AZN) regained some of the ground it lost on Monday after disappointing results from a trial of its lung cancer treatment, rising 3.1%.
Moderna, Inc. (NASDAQ:MRNA) rose 2.4% after it struck an agreement to develop its messenger-RNA medicines for China’s market.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.